Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the ability of growth hormone (GH, also known as
somatropin) to increase CD4+ cell counts in patients taking anti-HIV drugs. The study is
targeted toward patients with low levels of HIV who continue to have low CD4+ cell counts.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)